26 completed, 5 recruiting, 2 active not recruiting, 2 enrolling by invitation. 16 Phase 1, 11 Phase 3, 3 Phase 2, 2 Phase 4.
By phase and status
Follow insulin icodec: new trials by email Literature Review of insulin icodec trials Research Report on insulin icodec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes
Insulin icodec - Type 2 Diabetes | Phase 4 | Not yet recruiting | Xi'an International Medical Center Hospital | 462 | 2027-01-01 | 2026-08-05 |
Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
Insulin icodec - Diabetes Mellitus, Type 2 | | Enrolling by invitation | Novo Nordisk A/S | 216 | 2026-07-02 | 2026-09-15 |
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
UBT38006, Placebo, Insulin Degludec Injection - Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Recruiting | The United Bio-Technology (Hengqin) Co., Ltd. | 53 | 2026-06-17 | 2026-09-15 |
A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
Insulin icodec - Diabetes Mellitus, Type 2 | | Enrolling by invitation | Novo Nordisk A/S | 214 | 2026-05-28 | 2026-09-18 |
Clinical Trials of IBI3035 in Healthy Subjects
IBI3035, Insulin icodec Injection - Healthy Person | Phase 1 | Recruiting | Innovent Biologics (Suzhou) Co. Ltd. | 144 | 2026-05-08 | 2026-07-16 |
A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
Insulin icodec - Diabetes Mellitus, Type 1 | | Active not recruiting | Novo Nordisk A/S | 245 | 2025-08-28 | 2026-09-25 |
Comparison Study of Insulin GZR4 With Insulin Degludec
GZR4 injection - Type 2 Diabetes | Phase 1 | Recruiting | Gan and Lee Pharmaceuticals, USA | 14 | 2025-08-15 | 2025-08-28 |
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
Insulin icodec, Basal insulin analogues - Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | Novo Nordisk A/S | 586 | 2025-08-15 | 2026-08-11 |
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Insulin icodec, Insulin glargine, Insulin aspart - Diabetes Mellitus, Type 1 | Phase 3 | Active not recruiting | Novo Nordisk A/S | 877 | 2025-08-11 | 2026-09-25 |
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Insulin Icodec - Diabetes Mellitus, Type 1 | | Recruiting | Novo Nordisk A/S | 630 | 2025-04-15 | 2026-08-27 |
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Insulin icodec, Insulin glargine - Diabetes, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 412 | 2024-04-19 | 2026-08-11 |
A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting
Insulin icodec, Insulin degludec - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Novo Nordisk A/S | 30 | 2024-02-26 | 2026-06-08 |
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Insulin Icodec, Semaglutide - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 148 | 2023-09-22 | 2026-06-03 |
A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers
Insulin icodec - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Novo Nordisk A/S | 18 | 2023-04-25 | 2026-04-09 |
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
Insulin Icodec - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 51 | 2023-04-11 | 2026-04-30 |
A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
IcoSema, insulin icodec, semaglutide - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Novo Nordisk A/S | 20 | 2022-06-22 | 2025-03-21 |
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
IcoSema, Insulin icodec - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 1291 | 2022-06-01 | 2025-12-04 |
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Insulin icodec, Insulin glargine, Insulin aspart - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 582 | 2021-05-14 | 2025-12-04 |
A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
insulin icodec, insulin degludec, insulin aspart - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Novo Nordisk A/S | 582 | 2021-04-30 | 2025-12-04 |
A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes
insulin icodec - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Novo Nordisk A/S | 24 | 2021-04-28 | 2023-05-17 |
Showing 20 of 36. Sign in to see all of them.
Conditions studied
Diabetes Mellitus, Type 2 (29) · Diabetes Mellitus, Type 1 (6) · Diabetes Mellitus (2)
Sponsors
Novo Nordisk A/S (32) · Gan and Lee Pharmaceuticals, USA (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · The United Bio-Technology (Hengqin) Co., Ltd. (1) · Xi'an International Medical Center Hospital (1)
Countries
Germany (15) · United States (14) · Poland (9) · China (8) · Italy (8) · Japan (8) · Canada (7) · Puerto Rico (6) · Austria (5) · Czechia (5) · India (5) · Slovakia (5) · Bulgaria (4) · Mexico (4) · Russia (4)
Top investigators
Qiuhe Ji (1)
Results publications
PMID 36106652, PMID 40465144, PMID 40186685, PMID 42814374, PMID 39344833, PMID 39368488, PMID 41051694, PMID 38722461, PMID 32960514, PMID 33875484, PMID 33875485, PMID 34413118, PMID 36631720, PMID 37148899, PMID 37156252, PMID 37354562, PMID 37356066, PMID 37748181, PMID 37863084, PMID 38379002, PMID 39374601, PMID 39699848, PMID 40016570, PMID 40040516, PMID 40482671, PMID 40742780, PMID 41051695, PMID 42168822, PMID 42306490, PMID 42387301, PMID 42387310, PMID 42557064
NIH funding
2018 (4), 2017 (2), 2019 (2), 2023 (2), 2016 (1)